Glycemic Control: Clinical Trials

1 trial for Glycemic Control, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Glycemic Control: new trials by email Literature Review of Glycemic Control trials Research Report on Glycemic Control

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Fasiglifam (TAK-875), Sitagliptin, Placebo - Glycemic Control
Phase 3TerminatedTakeda9162012-04-012016-06-02

Interventions

Sitagliptin Phosphate (1)  ·  TAK-875 (1)

Sponsors

Takeda (1)

Countries

Australia (1)  ·  Bulgaria (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Hungary (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Slovakia (1)  ·  South Korea (1)  ·  Thailand (1)  ·  United States (1)

Results publications

PMID 30880443